Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Stem cells

Cell therapy for cardiac repair: what is needed to move forward?

Nature Reviews Cardiology volume 14, pages 257–258 (2017)Cite this article

Subjects

The ESC has updated its 2006 consensus statement on clinical investigation of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure. This initiative by a group of leaders in the field stimulates much-needed reflection and provides guidance to make cell therapy a clinical reality. Here, we offer our own perspective.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Effect of repeated cell therapy on left ventricular function.

References

  1. Mathur, A. et al. The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehw640 (2017).

  2. Keith, M. C. & Bolli, R. “String theory” of c-kitpos cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results. Circ. Res. 116, 1216–1230 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gyongyosi, M. et al. Meta-analysis of cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ. Res. 116, 1346–1360 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fisher, S. A., Doree, C., Mathur, A., Taggart, D. P. & Martin-Rendon, E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst. Rev. 12, CD007888 (2016).

    PubMed  Google Scholar 

  5. Khan, A. R. et al. Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis. Circ. Res. 118, 984–993 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bolli, R. Repeated cell therapy: a paradigm shift whose time has come. Circ. Res. http://dx.doi.org/10.1161/CIRCRESAHA.117.310710 (2017).

  7. Guo, Y. et al. Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Res. Cardiol. 112, 18 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tokita, Y. et al. Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy. Circ. Res. 119, 635–651 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jones, S. P. et al. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. Circ. Res. 116, 572–586 (2015).

    Article  CAS  PubMed  Google Scholar 

  10. Bolli, R. & Ghafghazi, S. Cell therapy needs rigorous translational studies in large animal models. J. Am. Coll. Cardiol. 66, 2000–2004 (2015).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are supported by NIH Grants HL-113530 and HL-78825.

Author information

Authors and Affiliations

  1. Roberto Bolli and Shahab Ghafghazi are at the Division of Cardiovascular Medicine and Institute of Molecular Cardiology, University of Louisville, 550 South Jackson Street, Louisville, Kentucky 40259, USA.,

    Roberto Bolli & Shahab Ghafghazi

Authors
  1. Roberto Bolli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahab Ghafghazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Bolli.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bolli, R., Ghafghazi, S. Cell therapy for cardiac repair: what is needed to move forward?. Nat Rev Cardiol 14, 257–258 (2017). https://doi.org/10.1038/nrcardio.2017.38

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2017.38

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing